Perigon Wealth Management LLC Reduces Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Perigon Wealth Management LLC cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 10.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,569 shares of the exchange traded fund’s stock after selling 650 shares during the quarter. Perigon Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $497,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Roundview Capital LLC raised its stake in SPDR S&P Biotech ETF by 275.4% during the first quarter. Roundview Capital LLC now owns 7,599 shares of the exchange traded fund’s stock valued at $683,000 after buying an additional 5,575 shares during the last quarter. U.S. Capital Wealth Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the first quarter valued at approximately $222,000. Synovus Financial Corp increased its position in shares of SPDR S&P Biotech ETF by 559.1% during the first quarter. Synovus Financial Corp now owns 15,462 shares of the exchange traded fund’s stock valued at $1,390,000 after acquiring an additional 13,116 shares in the last quarter. Vontobel Holding Ltd. raised its holdings in SPDR S&P Biotech ETF by 6.7% in the 1st quarter. Vontobel Holding Ltd. now owns 6,400 shares of the exchange traded fund’s stock worth $575,000 after acquiring an additional 400 shares during the last quarter. Finally, Sequoia Financial Advisors LLC boosted its stake in SPDR S&P Biotech ETF by 17.6% during the 1st quarter. Sequoia Financial Advisors LLC now owns 2,234 shares of the exchange traded fund’s stock valued at $201,000 after purchasing an additional 334 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $86.34 on Tuesday. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52. The business’s fifty day moving average is $93.95 and its 200 day moving average is $84.04. The stock has a market capitalization of $6.71 billion, a PE ratio of 11.47 and a beta of 1.08.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.